Clinical Characteristics of Coronavirus Disease (COVID-19) in Mexican Children and Adolescents


Por: Flores-Alanis, Alejandro, Saldaña-Ahuactzi Z., Parra-Ortega, Israel, Lopez-Ramirez, Pablo, Salazar-Garcia, Marcela, Aleman-Garcia, Yolanda P., Cruz-Rangel, Armando, Moreno-Paredes, Alba, Diaz-Rojas, Adrian, Maldonado-Bernal, Carmen, Quevedo-Moran, Jessica, Luna-Pineda, Victor M.

Publicada: 1 oct 2022
Resumen:
Background: We analyzed the demographic, clinical, and diagnostic data of children and adolescents in Mexico, from the first case of coronavirus disease (COVID-19) to 28 February 2022. Methods: Using the open databases of the Ministry of Health and a tertiary pediatric hospital, we obtained demographic and clinical data from the beginning of the COVID-19 pandemic until 28 February 2022. In addition, quantitative reverse-transcription polymerase chain reaction outputs were used to determine the viral load, and structural protein-based serology was performed to evaluate IgG antibody levels. Results: Of the total 437,832 children and adolescents with COVID-19, 1187 died. Of these patients, 1349 were admitted to the Hospital Infantil de Mexico Federico Gomez, and 11 died. Obesity, asthma, and immunosuppression were the main comorbidities, and fever, cough, and headache were the main symptoms. In this population, many patients have a low viral load and IgG antibody levels. Conclusion: During the first 2 years of the COVID-19 pandemic in Mexico, children and adolescents had low incidence and mortality. They are a heterogeneous population, but many patients had comorbidities such as obesity, asthma, and immunosuppression; symptoms such as fever, cough, and headache; and low viral load and IgG antibodies.

Filiaciones:
Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, 04510, Mexico
Paul G. Allen School for Global Health, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, United States
Laboratorio Central, Hospital Infantil de México Federico Gómez, Ciudad de México, 06720, Mexico
Centro de Investigación en Ciencias de Información Geoespacial (CentroGeo), Ciudad de México, 14240, Mexico
Laboratorio de Biología del Desarrollo y Teratogénesis Experimental, Hospital Infantil de México Federico Gómez, Ciudad de México, 06720, Mexico
Laboratorio de Investigación en COVID-19, Hospital Infantil de México Federico Gómez, Ciudad de México, 06720, Mexico
Laboratorio de Bioquímica de Enfermedades Crónicas, Instituto Nacional de Medicina Genómica, Ciudad de México, 14610, Mexico
Unidad de Investigación en Inmunología y Proteómica, Hospital Infantil de México Federico Gómez, Ciudad de México, 06720, Mexico
Licenciatura en Medicina, Facultad de Medicina, Benemérita Universidad Autónoma Puebla, Puebla, 72410, Mexico
Licenciatura en Químico Farmacéutico Industrial, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, 11340, Mexico
Licenciatura en Químico Bacteriólogo Parasitólogo, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, 11340, Mexico
ISSN: 19994915





Viruses-Basel
Editorial
MDPI AG, POSTFACH, CH-4005 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 14 Número: 10
Páginas:
WOS Id: 000875997400001
ID de PubMed: 36298717
imagen gold, Green Published, All Open Access, Gold, Green

MÉTRICAS